Resistant Cancer Mutations Require This New Strategy

Resistant Cancer Mutations Require This New Strategy

Author: Dr. Dino Prato - Envita Medical Centers February 19, 2026 Duration: 13:15
If you’ve been told you have a KRAS mutation — or another so-called “undruggable” cancer gene — you may have been placed on a specialty inhibitor designed to slow the disease. And these drugs can be helpful. But there’s a critical truth most patients are never told: Most targeted cancer drugs are cytostatic, not cytotoxic. They slow cancer down — they don’t eliminate it. In this episode of Outsmart Cancer, Dr. Dino Prato explains why drugs targeting KRAS, BRAF, EGFR, MET, HER2, and similar ...

For anyone navigating a cancer diagnosis, the standard treatment path can feel both overwhelming and impersonal. OutSmart Cancer-Precision Oncology. Less Guess Work. More Life! moves beyond that generic approach, diving into the nuanced world of personalized medicine. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, conversations here are built on a quarter-century of clinical experience helping patients for whom conventional protocols weren't enough. You'll hear detailed discussions that demystify complex topics like genomic testing, targeted therapies, and how integrative strategies can support the body during treatment. This isn't about promoting easy answers; it's about exploring the detailed, often overlooked factors that influence cancer progression and recovery. Each episode aims to translate cutting-edge science and hard-earned clinical wisdom into actionable knowledge, empowering you and your loved ones to ask better questions and understand the full spectrum of options. Tune in for a resource that treats your journey with the specificity it deserves, fostering informed dialogue between patients and their healthcare teams. This podcast serves as a guide for those determined to look deeper into their care, emphasizing a strategy tailored to the individual rather than the disease alone.
Author: Language: en-us Episodes: 100

OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!
Podcast Episodes
Root Canals & Cancer — What Patients Need to Know | Dr. Dino Prato [not-audio_url] [/not-audio_url]

Duration: 10:17
When a 52-year-old woman experienced breast cancer recurrence after initial radiation therapy, her oncologist considered a stronger chemotherapy regimen. However, her compromised immune system and high inflammation in th…
Cancer Survival Rates Are Misleading | Here's Why [not-audio_url] [/not-audio_url]

Duration: 11:12
In January 2026, the American Cancer Society announced a 70% cancer survival rate, a statistic that can be misleading to a cancer patient. Dr. Prato clarifies the nuances behind this data, emphasizing that while there's…
This New Cancer Device Just Got FDA Approval [not-audio_url] [/not-audio_url]

Duration: 8:22
A new device has received food and drug administration approval for pancreatic cancer, offering a new tool in cancer treatment. This wearable technology works by disrupting cancer cells, potentially slowing growth. While…